Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication
Tóm tắt
Từ khóa
Tài liệu tham khảo
Beasley, 1984, Epidemiology of hepatocellular carcinoma, 209
Civitico, 1990, Antiviral strategies in chronic hepatitis B virus infection: I. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds, J. Med. Virol., 30, 253
Chou, 1987, Synthesis and biological effects of 2′-fluoro-5-ethyl-1-B-D-arabinofuranouracil, Antimicrob. Agents Chemother., 31, 1355, 10.1128/AAC.31.9.1355
Finter, 1969, Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays, J. Gen. Virol., 5, 419, 10.1099/0022-1317-5-3-419
Fourel, 1990, Inhibitory effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks, Antimicrob. Agents Chemother., 34, 473, 10.1128/AAC.34.3.473
Gerin, 1989, Hepadnavirus-induced liver cancer in woodchucks, Cancer Prevention and Detection, 14, 227
Hoofnagle, 1991, Current status and future directions in the treatment of chronic viral hepatitis, 632
Lee, 1989, In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus, Antimicrob. Agents Chemother., 33, 336, 10.1128/AAC.33.3.336
Korba, 1991, Woodchuck hepatitis virus infection as a model for the development of antiviral therapies against HBV, 663
Korba, 1991, A cell culture assay for compounds which inhibit hepatitis B virus replication, Antiviral Res., 15, 217, 10.1016/0166-3542(91)90068-3
Korba, 1989, Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections, Hepatology, 9, 461, 10.1002/hep.1840090321
Korba, 1986, Hepadnavirus infection of peripheral blood lymphocytes in vivo: Woodchuck and chimpanzee models of viral hepatitis, J. Virol., 58, 1, 10.1128/JVI.58.1.1-8.1986
Lampertico, 1991, Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics, Hepatology, 13, 422
Matthes, 1990, Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides, Antimicrob. Agents Chemother., 34, 1986, 10.1128/AAC.34.10.1986
Popper, 1987, Relation of the hepatitis B virus carrier state to hepatocellular carcinoma, Hepatology, 7, 764, 10.1002/hep.1840070425
Price, 1989, Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine, 86, 806
Thomas, 1987, Treatment of hepatitis B viral infection, 817
Schaeffer, 1970, Structure-activity relationships in adenosine deaminase inhibitors, J. Med. Chem., 13, 452, 10.1021/jm00297a026
Seeger, 1986, Biochemical and genetic evidence for the hepatitis B virus replication strategy, Science, 232, 477, 10.1126/science.3961490
Sells, 1988, Replication intermediates of hepatitis B virus in HepG2 cells that produce infectious virions, J. Virol., 62, 2836, 10.1128/JVI.62.8.2836-2844.1988
Summers, 1982, Replication of the genome of a hepatitis-B-like virus by reverse transcription of an RNA intermediate, Cell, 29, 403, 10.1016/0092-8674(82)90157-X
Suzuki, 1988, Inhibition of duck hepatitis B virus replication by purine 2′,3′-dideoxynucleosides, Biochem. Biophys. Res. Commun., 156, 1144, 10.1016/S0006-291X(88)80752-6
Ueda, 1989, An in vitro system for screening antihepatitis B virus drugs, Virology, 169, 213, 10.1016/0042-6822(89)90057-3
Van Aerschot, 1990, Synthesis and anti-HIV evaluation of 2′,3′-dieoxyribochloropyrimidine analogues: Reduced toxicity of 5-chlorinated 2′,3′-dideoxynucleosides, J. Med. Chem., 33, 1833, 10.1021/jm00168a046